Human Leukocyte Antigen Testing Sample Clauses

Human Leukocyte Antigen Testing. This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.
Sample 1Sample 2Sample 3See All (191)
AutoNDA by SimpleDocs
Human Leukocyte Antigen Testing. In accordance with Rhode Island General Law §27-20-36, we cover human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime for utilization in bone marrow transplantation. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.
Sample 1Sample 2Sample 3See All (60)
Human Leukocyte Antigen Testing. Human leukocyte antigen testing 0% - After deductible 20% - After deductible
Sample 1Sample 2Sample 3See All (9)
Human Leukocyte Antigen Testing. In accordance with Rhode Island General Law § 27-20-36, we cover human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime for utilization in bone marrow transplantation. The testing must be performed in a facility which is:
Sample 1Sample 2
Human Leukocyte Antigen Testing. To the extent that coverage for bone marrow or stem cell transplantation is more limited than the coverage required to be covered for "New Cancer Therapies," the applicable provisions of the Rhode Island Laws shall govern. See Section 7.0 for the definition of experimental/investigational services. Multiple Surgeries When a doctor performs more than one procedure in a day, there are rules that may reduce our allowance for the additional procedure. Our allowance may also include post-operative care and other procedures provided within specified time periods. If More Than One Surgeon Operates In addition to the type and purpose of surgery, our allowance differs depending on the number of surgeons involved, including assistant surgeons. If two (2) surgeons perform separate operations during a single surgical session, each surgeon may submit a claim reporting the procedure performed and the circumstances involved. These claims will then be evaluated for payment on an individual basis.
Sample 1Sample 2
Human Leukocyte Antigen Testing. Human leukocyte antigen testing 20% - After Deductible 40% - After Deductible Covered Benefits Network Providers You Pay Non-network Providers You Pay See Section 3.0 – Covered Health Care Services for additional benefit limits and coverage information. Infertility Treatment Inpatient/outpatient/in a doctor’s office Three (3) infertility treatment cycles will be covered per plan year with a total of eight (8) infertility treatment cycles covered in a member’s lifetime. 20% - After Deductible 20% - After Deductible Infusion Therapy Administration Outpatient - hospital 20% - After Deductible 40% - After Deductible In the doctor’s office/in your home 20% - After Deductible 40% - After Deductible Inpatient Services General hospital or specialty hospital services* Unlimited days 20% - After Deductible 40% - After Deductible Rehabilitation facility services* Limited to 45 days per plan year. 20% - After Deductible 40% - After Deductible Physician hospital visits 20% - After Deductible 40% - After Deductible
Sample 1

Related to Human Leukocyte Antigen Testing

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act.

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

  • Biological Samples If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee Biological Samples (“Biological Samples”). 12.2.

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Drug Test The compulsory production and submission of urine and/or blood, in accordance with departmental procedures, by an employee for chemical analysis to detect prohibited drug usage.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Random Testing Notwithstanding any provisions of the Collective Agreement or any special agreements appended thereto, section 4.6 of the Canadian Model will not be applied by agreement. If applied to a worker dispatched by the Union, it will be applied or deemed to be applied unilaterally by the Employer. The Union retains the right to grieve the legality of any imposition of random testing in accordance with the Grievance Procedure set out in this Collective Agreement.

  • Influenza Vaccination The parties agree that influenza vaccinations may be beneficial for patients and employees. Upon a recommendation pertaining to a facility or a specifically designated area(s) thereof from the Medical Officer of Health or in compliance with applicable provincial legislation, the following rules will apply:

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

Time is Money Join Law Insider Premium to draft better contracts faster.